About us

Our laboratory has elucidated the contribution of rare de novo and inherited mutations to the genetic risk of schizophrenia and develops relevant model systems to understand their impact on neural mechanisms and advance neuropsychiatric therapeutics. 


Featured Publications

Recent Publication


July 27, 2018

New Uses for Old Medications

Even drugs whose development was stalled or canceled might show promise for illnesses they were never meant to treat